Novo Nordisk | Des Atouts



Assets Changement Date
ANI Pharmaceuticals USD 1.29B 8.73M 2025-03
Aurora Cannabis CAD 866.52M 57.75M 2024-12
Bausch Health Companies USD 26.42B 102M 2025-03
Bristol-Myers Squibb USD 92.43B 176M 2025-03
Canopy Growth CAD 1.16B 68.13M 2024-12
Corcept Therapeutics USD 846.46M 5.9M 2025-03
Drreddys Laboratories INR 481.06B 15.1B 2024-12
Eli Lilly USD 89.39B 10.67B 2025-03
GlaxoSmithKline GBP 60.71B 1.24B 2025-03
Merck USD 115.12B 1.98B 2025-03
Novartis USD 102.25B 1.28B 2024-12
Novo Nordisk 489.16B 91.72B 2025-03
Novo Nordisk DKK 397.44B 28.06B 2024-09
Pacira USD 1.59B 33.15M 2025-03
Perrigo USD 9.76B 112.1M 2025-03
Prestige Brands USD 3.4B 72.72M 2025-03
Sanofi 131.89B 906M 2025-03
Supernus Pharmaceuticals USD 1.37B 25.37M 2024-12
Zoetis USD 14.1B 139M 2025-03



Novo Nordisk Des Atouts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.